Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Donald Kufe
Dana Farber Cancer Inst, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Genus Oncology
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see attached
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
PROJECT NARRATIVE The MUC1-C oncoprotein is aberrantly overexpressed in human carcinomas and activates a program of immune evasion. However, no therapeutic approaches have been developed clinically against this highly important cancer target. In addressing this unmet need, the proposed research focuses on the development of agents directed against the MUC1-C extracellular and cytoplasmic domains. The goal of these studies is to develop clinical candidates that target MUC1-C as novel immunotherapeutics for treatment of solid tumors.
Filed on November 15, 2018.
Tell us what you know about Donald Kufe's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Donald Kufe filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | $150,000 - $199,999 |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | $150,000 - $199,999 |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | $150,000 - $199,999 |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | $150,000 - $199,999 |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | $100,000 - $149,999 |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | $100,000 - $149,999 |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | $100,000 - $149,999 |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | $0 - $4,999 |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | Value cannot be readily determined |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | Value cannot be readily determined |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | Value cannot be readily determined |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | Value cannot be readily determined |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | Value cannot be readily determined |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | Value cannot be readily determined |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | Value cannot be readily determined |
| Donald Kufe | Dana Farber Cancer Inst | Conflict of Interest | Genus Oncology | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.